Drug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering -...

|About: Synageva BioPharma Corp. (GEVA)|By:, SA News Editor

Drug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering - equal to 13.6% of its market cap as of today's close. The company only says it plans to use the proceeds for "general corporate purposes." (prospectus)